Novo Nordisk says it is gradually phasing out human insulin pens globally
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
Comparing Oral vs. Injectable Semaglutide: Is One More Effective Than the Other?
It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...
As insulin shortages persist, what diabetes patients can do
Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...
drugdeliverybusiness3h
The biggest diabetes tech stories of the year so far
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
FiercePharma3d
MSF calls on Lilly, Novo and Sanofi to cut insulin pen prices to $1
Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...
medtechdive1d
Dean Kamen, insulin pump pioneer, wants to shake up diabetes tech
Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...
Independent pharmacists blame ‘medical middlemen’ for soaring drug costs, pharmacy closures
NEW ORLEANS (WVUE) - If you have trouble affording prescription drugs, some independent pharmacists say that so-called ...
24/7 Wall St on MSN6d
These Life-Changing Inventions Were Happy Accidents
Insights Some of the most important inventions ever were created by accident.  Viagra is a surprising addition to this list ...
The Times of Northwest Indiana13d
Reduce your risk of diabetes with these 5 healthy lifestyle tips
C Midwest Express Clinic. Discover five practical tips that you can incorporate into your day-to-day routine to help prevent ...
USA Today21d
As insulin shortages persist, what diabetes patients can do
Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...